BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 19318446)

  • 1. Low serum levels of sex steroids are associated with disease characteristics in primary Sjogren's syndrome; supplementation with dehydroepiandrosterone restores the concentrations.
    Forsblad-d'Elia H; Carlsten H; Labrie F; Konttinen YT; Ohlsson C
    J Clin Endocrinol Metab; 2009 Jun; 94(6):2044-51. PubMed ID: 19318446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex steroid hormones in primary Sjögren's syndrome.
    Brennan MT; Sankar V; Leakan RA; Grisius MM; Collins MT; Fox PC; Baum BJ; Pillemer SR
    J Rheumatol; 2003 Jun; 30(6):1267-71. PubMed ID: 12784401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dehydroepiandrosterone (DHEA) substitution treatment for severe fatigue in DHEA-deficient patients with primary Sjögren's syndrome.
    Virkki LM; Porola P; Forsblad-d'Elia H; Valtysdottir S; Solovieva SA; Konttinen YT
    Arthritis Care Res (Hoboken); 2010 Jan; 62(1):118-24. PubMed ID: 20191499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of oral DHEA treatment to increase local salivary androgen outputs of female patients with Sjögren's syndrome.
    Porola P; Straub RH; Virkki LM; Konttinen YT; Nordström DC
    Scand J Rheumatol; 2011; 40(5):387-90. PubMed ID: 21877998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjögren's syndrome.
    Pillemer SR; Brennan MT; Sankar V; Leakan RA; Smith JA; Grisius M; Ligier S; Radfar L; Kok MR; Kingman A; Fox PC
    Arthritis Rheum; 2004 Aug; 51(4):601-4. PubMed ID: 15334433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are women with Sjögren's syndrome androgen-deficient?
    Sullivan DA; Bélanger A; Cermak JM; Bérubé R; Papas AS; Sullivan RM; Yamagami H; Dana MR; Labrie F
    J Rheumatol; 2003 Nov; 30(11):2413-9. PubMed ID: 14677186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dehydroepiandrosterone administration on fatigue, well-being, and functioning in women with primary Sjögren syndrome: a randomised controlled trial.
    Hartkamp A; Geenen R; Godaert GL; Bootsma H; Kruize AA; Bijlsma JW; Derksen RH
    Ann Rheum Dis; 2008 Jan; 67(1):91-7. PubMed ID: 17545193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sjögren's syndome and extragonadal sex steroid formation: a clue to a better disease control?
    Konttinen YT; Stegajev V; Al-Samadi A; Porola P; Hietanen J; Ainola M
    J Steroid Biochem Mol Biol; 2015 Jan; 145():237-44. PubMed ID: 25158020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low serum dehydroepiandrosterone sulfate in women with primary Sjögren's syndrome as an isolated sign of impaired HPA axis function.
    Valtysdóttir ST; Wide L; Hällgren R
    J Rheumatol; 2001 Jun; 28(6):1259-65. PubMed ID: 11409117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of sex steroids and metabolites following 12 weeks of intravaginal 0.50% DHEA administration.
    Ke Y; Labrie F; Gonthier R; Simard JN; Bergeron D; Martel C; Vaillancourt M; Montesino M; Lavoie L; Archer DF; Balser J; Moyneur E;
    J Steroid Biochem Mol Biol; 2015 Nov; 154():186-96. PubMed ID: 26291918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen deficiency and defective intracrine processing of dehydroepiandrosterone in salivary glands in Sjögren's syndrome.
    Porola P; Virkki L; Przybyla BD; Laine M; Patterson TA; Pihakari A; Konttinen YT
    J Rheumatol; 2008 Nov; 35(11):2229-35. PubMed ID: 18843777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low salivary dehydroepiandrosterone and androgen-regulated cysteine-rich secretory protein 3 levels in Sjögren's syndrome.
    Laine M; Porola P; Udby L; Kjeldsen L; Cowland JB; Borregaard N; Hietanen J; Ståhle M; Pihakari A; Konttinen YT
    Arthritis Rheum; 2007 Aug; 56(8):2575-84. PubMed ID: 17665393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a 3-week dehydroepiandrosterone administration on sleep, sex steroids and multiple 24-h hormonal profiles in postmenopausal women: a pilot study.
    Caufriez A; Leproult R; L'Hermite-Balériaux M; Kerkhofs M; Copinschi G
    Clin Endocrinol (Oxf); 2013 Nov; 79(5):716-24. PubMed ID: 23488643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of sex steroids on Sjögren's syndrome.
    Porola P; Laine M; Virkki L; Poduval P; Konttinen YT
    Ann N Y Acad Sci; 2007 Jun; 1108():426-32. PubMed ID: 17894007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
    Labrie F; Bélanger A; Cusan L; Candas B
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging.
    Labrie F; Bélanger A; Cusan L; Gomez JL; Candas B
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2396-402. PubMed ID: 9253307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Traditional Chinese medicine compound ShengJinRunZaoYangXue granules for treatment of primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled clinical trial.
    Hu W; Qian X; Guo F; Zhang M; Lyu C; Tao J; Gao Z; Zhou Z
    Chin Med J (Engl); 2014; 127(15):2721-6. PubMed ID: 25146603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.
    Morales AJ; Nolan JJ; Nelson JC; Yen SS
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1360-7. PubMed ID: 7515387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of rituximab treatment in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled trial.
    Meijer JM; Meiners PM; Vissink A; Spijkervet FK; Abdulahad W; Kamminga N; Brouwer E; Kallenberg CG; Bootsma H
    Arthritis Rheum; 2010 Apr; 62(4):960-8. PubMed ID: 20131246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.